We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
One of the biggest mistakes a medical device company can make when using an independent sales force is neglecting the situation where sales representatives are disinclined to do the legwork of building up a product's market when the manufacturer is likely to sell out to a bigger company or switch to a direct sales force, according to Rick Davies, managing partner at Vector Resources.
A congressional committee has requested that Amgen and Johnson & Johnson (J&J) stop direct-to-consumer (DTC) advertising for erythropoiesis-stimulating agents (ESAs).
Demand for nanotechnology medical products will grow by more than 17 percent annually to reach $53 billion in 2011, according to a recent report from The Freedonia Group.
HHS Secretary Michael Leavitt is calling for a new healthcare system in the U.S. modeled after the Medicare Part D drug benefit and based on competition and quality standards.
HHS Secretary Michael Leavitt is calling for a new healthcare system in the U.S. modeled after the Medicare Part D drug benefit and based on competition and quality standards.
Pfizer’s market-leading cholesterol medication Lipitor lost 4.6 market share points in 2006 despite 12.7 percent growth in the cholesterol market, according to IMS Health data.
Schering-Plough is buying Organon BioSciences, the human and animal healthcare unit of Akzo Nobel, for $14.4 billion to supplement its late-stage product pipeline, the company announced.